Follow the American Healthcare REIT, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Real Estate sector, American Healthcare REIT, Inc. has recorded 155 insider filings. Market capitalisation: €11.1bn. The latest transaction was filed on 29 June 2026 (Cession). Among the most active insiders: PEAY BRIAN. All data is free.
Analysts rate American Healthcare REIT, Inc. Strong Buy (bullish), based on 14 analysts. Average price target: US$58.43.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 155 declarations
American Healthcare REIT, Inc. (NYSE: AHR) is a U.S.-listed real estate investment trust focused on healthcare property. For French-, Belgian- and Swiss-based investors, it represents a specialized exposure to a defensive but operationally complex real estate niche: healthcare real estate in the United States. The company owns and operates a diversified portfolio of clinical healthcare properties, with a primary focus on senior housing communities, skilled nursing facilities, and outpatient medical office buildings. Its footprint is not limited to the United States; the company also reports assets in the United Kingdom and the Isle of Man, giving it an international dimension within the healthcare REIT universe. American Healthcare REIT has been built around a targeted investment strategy in healthcare-related real estate. Investor materials indicate that the platform is organized around several operating and property segments, with meaningful exposure to senior housing and skilled nursing, alongside outpatient medical buildings. This mix is important because it combines more traditional rent-based real estate cash flows with more operationally driven assets, depending on the property type and operator model. In practice, that makes AHR a specialized healthcare real estate platform rather than a broad-based property company. That specialization can be an advantage in underwriting assets, understanding operator economics, and sourcing properties aligned with long-duration demand trends. From a competitive standpoint, the company operates in a market where tenant quality, local demand depth, reimbursement sensitivity, and lease structure matter materially. AHR’s value proposition is centered on diversified healthcare property exposure, a portfolio designed around essential care settings, and the ability to acquire, own, and operate healthcare real estate at scale. Publicly available investor materials have described the portfolio as having a gross investment value of roughly $4.2 billion, placing the company among the more notable healthcare REITs, though not in the largest mega-cap tier of the sector. In terms of recent developments, American Healthcare REIT announced full-year 2025 results and stated that it achieved more than 20% NFFO per share growth in 2025 versus the prior year, while also providing full-year 2026 guidance. The company also announced in January 2026 the timing of its fourth-quarter 2025 earnings release. For investors, the key ongoing themes are execution on acquisitions, capital funding, occupancy improvement, and margin expansion across the portfolio. The NYSE listing in the United States gives AHR strong visibility among institutional investors and reinforces its profile as a focused healthcare real estate name.